Co-trimoxazole prophylaxis: the debates continue.

Abstract

Use of prophylactic co-trimoxazole (alone or alongside other drugs) is one of the most debated therapeutic interventions for patients with HIV in sub-Saharan Africa. This debate extends to the complexities of establishing the best timing of initiation and dosing and whether coadministration of the drug should be discontinued after immunological recovery… (More)
DOI: 10.1016/S2352-3018(15)00019-3

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.